Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to the pharmaceutical company. The nasal spray can be given to people who haven’t seen ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...
The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback